While the FDA tries to block commercial application of stem cell therapies in the US, veterinary practices continue to demonstrate that the technology is ready and potentially useful: “A Golden Retriever, plagued with arthritis, recently underwent a stem cell extraction and implant to help with mobility. … From the sounds of things, you would never suspect McIntyre was a frail and feeble dog. And these days, he’s moving around pretty well, thanks to anti-inflammatory medicines, physical therapy and a new experimental surgery involving stem cells. … like family, she wanted McIntrye to feel better and have a better quality of life. Cells were taken from his belly fat and shipped to California. Stem cells were extracted and then implanted back into his joints by a vet in Alpharetta. … He’ll never be like a puppy as far as agility but it will just give him a quality of life where he doesn’t hurt and suffer.” Meanwhile, the actions of unaccountable, unelected bureaucrats at the FDA mean that US residents must travel overseas to find the same treatment offered to humans. More importantly, what might already be a wildly successful and growing field is slowed down to a comparative crawl. When you’re forbidden to sell a product, few organization will invest in development.

View the Article Under Discussion: http://www.walb.com/Global/story.asp?S=12964756

Read More Longevity Meme Commentary: http://www.longevitymeme.org/news/